Latest Strategy News

Benz Mining reports significant high-grade gold intercepts at its Glenburgh Gold Project, confirming continuity and expanding resource potential. The company advances its maiden resource estimate with a fully funded 30,000m drill program underway.

Theta Gold Mines has approved the Decision to Mine for its TGME Gold Project in South Africa and raised US$4 million through a private placement, advancing its path toward production amid rising gold prices.

ECS Botanics has launched the globally acclaimed Terphogz™ cannabis strains, including The Original Z™, into the Australian medicinal market, marking a strategic expansion of its premium product portfolio.

Redcastle Resources has significantly boosted its gold Mineral Resource Estimates to 42,000 ounces across its Queen Alexandra and Redcastle Reef deposits, marking a 280% increase from its maiden resource. The company is advancing towards near-term production with a strategic partnership and ongoing scoping study.

Estrella Resources has confirmed a $5 million capital injection from a strategic investor exercising a tranche subscription option, underpinning its ambitious manganese and limestone projects in Timor-Leste.

NH3 Clean Energy has successfully raised $710,000 through a share placement, boosting funding for its WAH2 clean ammonia export project. This capital injection, alongside convertible note conversions, underscores progress toward the project's final investment decision.

Noble Helium has arranged a $200,000 unsecured loan from its Non-Executive Chair as a short-term refinancing measure, aiming to bolster working capital without diluting shareholders. The company plans a webinar to outline its refinancing and strategic direction.

Dimerix Limited has received a significant milestone payment from its Japanese partner FUSO Pharmaceutical, marking progress in the Phase 3 clinical trial of DMX-200 for kidney disease. This payment underscores the growing momentum behind Dimerix’s global licensing strategy.

LTR Pharma has successfully completed the extractables study for its intranasal erectile dysfunction spray SPONTAN, confirming safety compliance and initiating the next phase of leachables testing to support FDA approval.

Brightstar Resources has unveiled a definitive feasibility study for its Laverton-Menzies gold projects, outlining a clear growth trajectory targeting 70,000 ounces annually over five years and aiming for 200,000 ounces by 2029.

BlinkLab has secured US Institutional Review Board approval to proceed with the main phase of its FDA 510(k) trial for an AI-powered autism diagnostic tool, marking a key step toward regulatory clearance.

D3 Energy reports a significant 32% increase in gas flow rates at its RBD03 well in South Africa following a well clean-out, reinforcing the project's development prospects.